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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
Accumulation of amyloid-b peptides (Ab), the pro-
teolytic products of the amyloid precursor protein
(APP), induces a variety of synaptic dysfunctions
ranging from hyperactivity to depression that are
thought to cause cognitive decline in Alzheimer’s
disease. While depression of synaptic transmission
has been extensively studied, the mechanisms
underlying synaptic hyperactivity remain unknown.
Here, we show that Ab40 monomers and dimers
augment release probability through local fine-tuning
of APP-APP interactions at excitatory hippocampal
boutons. Ab40 binds to the APP, increases the APP
homodimer fraction at the plasma membrane, and
promotes APP-APP interactions. The APP activation
induces structural rearrangements in the APP/Gi/o-
protein complex, boosting presynaptic calcium flux
and vesicle release. The APP growth-factor-like
domain (GFLD) mediates APP-APP conformational
changes and presynaptic enhancement. Thus, the
APP homodimer constitutes a presynaptic receptor
that transduces signal from Ab40 to glutamate
release. Excessive APP activation may initiate a
positive feedback loop, contributing to hippocampal
hyperactivity in Alzheimer’s disease.INTRODUCTION
Accumulation of amyloid-b (Ab) in the extracellular space of the
brain appears to be critical for developing synaptic and cognitive
deficits in Alzheimer’s disease (AD) (Palop and Mucke, 2010). Ab
is produced by sequential limited proteolysis of the amyloid1560 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authorsprecursor protein (APP), a type I single-transmembrane-span
protein (Kang et al., 1987), by two aspartyl proteases, b- and
g-secretases. Normally, g-secretase cleavage results in variable
38- to 43-amino-acid Ab peptides, with Ab40 monomers as the
predominant species. The biophysical and biochemical pro-
perties of Ab strongly depend on its concentration, length, and
primary structure. Gradual elevation of Ab monomers in limbic
and association cortices leads to its aggregation into oligomers,
prefibrillar assemblies (protofibrils), and amyloid fibrils. All of
these Ab forms may be in dynamic equilibrium, leading to a
high variety of synaptic and circuit dysfunctions that underlie
progressive cognitive impairments in AD (Mucke and Selkoe,
2012). Transient upregulation of Ab production or application
of pathological Ab levels depresses excitatory synaptic trans-
mission (Hsia et al., 1999; Kamenetz et al., 2003). Soluble Ab
oligomers have been suggested to cause postsynaptic depres-
sion of glutamatergic transmission via loss of dendritic spines,
blockade of long-term potentiation, and increase in long-term
synaptic depression (Shankar et al., 2008; Walsh et al., 2002).
While pathological Ab concentrations and assembly forms
depress excitatory synaptic function through postsynaptic
mechanisms, an increase in endogenous Ab levels induced by
inhibition of extracellular Ab degradation causes presynaptic
enhancement (Abramov et al., 2009). Specifically, inhibition of
the Ab-degrading enzyme neprilysin augmented glutamate
release probability, reduced short-term facilitation of excitatory
synaptic currents, and increased excitation-inhibition balance
in hippocampal circuits (Abramov et al., 2009). Because hippo-
campal and cortical hyperactivity is common in various trans-
genic AD mouse models (Busche et al., 2008, 2012; Palop
et al., 2007; Verret et al., 2012), in humans with mild cognitive im-
pairments (Bakker et al., 2012), and in AD patients (Vossel et al.,
2013), elucidating the synaptic mechanisms of hyperactivity is
critical for understanding AD-associated cognitive impairments.
In the current study, we explored the mechanism initiating
augmentation of synaptic vesicle release at excitatory
hippocampal synapses by increasing the extracellular Ab
concentration ([Ab]o) in cultured hippocampal neurons and acute
hippocampal slices. Utilizing a combination of fluorescence
resonance energy transfer (FRET) spectroscopy, a single-
molecule imaging, two-photon excitation laser scanning micro-
scopy combined with fluorescence lifetime imaging (2pFLIM),
biochemistry, and imaging of synaptic vesicle recycling and of
calcium, we found that the APP homodimer constitutes a pre-
synaptic Ab40 receptor mediating the regulation of release prob-
ability at excitatory hippocampal synapses.
RESULTS
APP Is Essential for Ab-Mediated Presynaptic
Enhancement
Concentrations of Ab in the synaptic cleft are determined by the
balance of Ab production, release, and degradation. We have
previously shown that inhibition of neprilysin, an Ab-degrading
enzyme, increases release probability in excitatory hippocampal
synapses (Abramov et al., 2009). Inhibition of neprilysin was inef-
fective in APP/ neurons, suggesting that APP and/or Ab
mediate the presynaptic enhancement. Here, we wished to
determine whether APP, in addition to being the source for Ab,
is also necessary for Ab-induced signaling leading to the
augmentation of basal transmitter release. We examined the
effect of human Ab1–40 (Ab40), the most abundant Ab isoform,
on basal synaptic vesicle recycling in cultured hippocampal neu-
rons using the activity-dependent dye FM1-43 as described
earlier (Abramov et al., 2009). To this end, we quantified the total
amount of releasable fluorescence at each bouton (DF) and the
density of FM+ puncta per image (D) following stimulation (30
action potentials at a rate of 0.2 Hz; Figure S1A) in the presence
of 10 mM FM1-43. Figure 1A illustrates a typical high-magnifica-
tion DF image before and after Ab40 application. The total
presynaptic strength within a given region of the hippo-
campal network (S) can be estimated as the product of DF and
D (S = DF 3 D). First, we measured the effect of size-exclusion
chromatography-isolated Ab40monomers (Figure S2) on synap-
tic vesicle turnover in cultured hippocampal neurons from wild-
type (WT) mice. Our results demonstrate that acute application
of Ab40 monomers (100 pM, 15 min) induced a substantial in-
crease in both DF and D across synaptic populations, resulting
in a 2-fold increase in the total presynaptic strength S in WT neu-
rons (Figures 1B and 1C). The collective results of these experi-
ments show a profound increase of S by Ab40 monomers in a
concentration-dependent manner (Figure 1I). Application of rat
Ab40 monomers produced a similar effect on presynaptic
strength (data not shown). Because covalently crosslinked
Ab40 dimers ([Ab40S26C]2) have been shown to enhance Ca
2+
transients in CA1 hippocampal neurons in vivo (Busche et al.,
2012), we assessed their effects (O’Nuallain et al., 2010; Fig-
ure S2) on presynaptic function. Notably, fresh [Ab40S26C]2 pro-
duced a presynaptic enhancement (100 pM; Figure 1D) similar to
the one induced by 100 pM Ab40 monomers.
Next, we assessed the effect of Ab40 in hippocampal neurons
produced from APP/ (Zheng et al., 1995) mice. Surprisingly,
the same concentrations of Ab40 monomers or Ab40S26C
dimers that increased presynaptic activity in WT neurons wereCineffective in neurons lacking APP (Figures 1E–1I). Expression
of WT APP in APP/ neurons rescued the presynaptic effect
of Ab40 (Figure S1B), suggesting that both Ab40 and its pre-
cursor, APP, are essential for augmentation of synaptic vesicle
recycling. Notably, the presynaptic Ab40 effect was not altered
by several Ab binding candidates such as cellular prion protein
(PrPC) or a7 nicotinic acetylcholine receptor (a7nAChR), because
Ab40 was still able to potentiate synaptic vesicle recycling in
hippocampal neurons produced from PrPC knockout mice or
following blockade of a7nAChR by a-bungarotoxin (Figure S1B).
Taken together, these results suggest that APP is necessary for
the presynaptic signaling mediated by Ab40 monomers and
dimers.
Monitoring APP-APP Interactions at Individual
Hippocampal Boutons
Previous studies in heterologous expression systems suggest
that APP molecules can form homodimers and that APP homo-
dimerization may regulate Ab production (Eggert et al., 2009;
Munter et al., 2007). Having established a critical role of APP in
the Ab40-mediated presynaptic enhancement, we next explored
the relationship between APP-APP interactions and synapse
release probability at individual hippocampal synapses. First,
we tested whether APP forms homodimers at the presynaptic
compartments. FRET spectroscopy enables studying conforma-
tional changes between fluorescently tagged proteins at the
single-synapse level (Laviv et al., 2010) by providing an accurate
measure of possible changes in the relative distance (<100 A˚)
and/or orientation between fluorophores. We transfected hippo-
campal cultures with APP C-terminally tagged with mCitrine
(APPCit) and with Cerulean (APPCer) (Figure 2A). FRET measure-
ments were taken from boutons of hippocampal neurons (Fig-
ures 2B and S4A). Presynaptic localization of the tagged APP
molecules in boutons was confirmed by colocalization of APPCit
with cyan fluorescent protein (CFP)-tagged synapsin Ia protein
(data not shown). We measured the steady-state mean FRET
efficiency (Em) utilizing the acceptor photobleaching method
(Figures 2C and 2D), which dequenches the donor (Cer). FRET
efficiency was measured in the presence of tetrodotoxin (TTX),
which blocks spike generation, allowing only miniature synaptic
release. To estimate Em using a spectroscopic approach, Cer/Cit
emissions were collected in the range of 400–600 nm using a
440 nm excitation wavelength at individual presynaptic boutons
expressing APPCer and APPCit proteins. A typical emission spec-
trum is displayed in Figure 2D. High-magnification confocal
images (Figure 2B) of the presynaptic bouton (marked by arrow-
head) show an increase in Cer fluorescence after Cit photo-
bleaching (Figure 2C), indicating dequenching of the donor and
the presence of FRET. Quantitative analysis of FRET signals
between APPCer and APPCit proteins across 86 functional bou-
tons from seven experiments under miniature synaptic activity
revealed a mean Em of 0.14 ± 0.01 (Figure 2E). The FRET level
varied across different boutons (coefficient of variation of
77%), suggesting different APP-APP conformational states at
the single-bouton level. Notably, higher FRET levels were
detected between APPCer and APPCit proteins expressed in
APP/ cultures, which were significantly reduced by coexpres-







Figure 1. APP Is Required for Ab40-Induced Presynaptic Enhancement
(A) Representative DF images before and 15 min after application of 100 pM Ab40 monomers in WT hippocampal culture. Stimulation during FM1-43 staining: 30
action potentials at 0.2 Hz; destaining: 1,000 action potentials at 2 Hz. Fluorescence intensities (arbitrary units [a.u.]) are coded using a pseudo-color trans-
formation. Scale bar, 2 mM.
(B) DF histograms before and after 100 pM Ab40 monomers application in a single experiment in WT hippocampal culture. The mean F increased from 76 to 100
a.u., and the number of FM (+) puncta increased from 220 to 331.
(C) Effects of Ab40 monomers (100 pM) on the total presynaptic strength in WT neurons (SAPP-WT, N = 12).
(D) Effects of Ab40S26C dimers (100 pM) on the total presynaptic strength in WT neurons (SAPP-WT, N = 14).
(E) RepresentativeDF images before and 15min after application of Ab40monomers inAPP/ neurons. Stimulation during FM1-43 staining: 30 action potentials
at 0.2 Hz; destaining: 1,000 action potentials at 2 Hz. Scale bar, 2 mM.
(F) DF histograms before and after 100 pM Ab40 monomers application in a single experiment in APP/ neurons.
(G) Ab40 monomers (100 pM) do not affect the total presynaptic strength in APP/ neurons (SAPP-KO, N = 12).
(H) [Ab40S26C]2 (100 pM) do not affect the total presynaptic strength in APP
/ neurons (SAPP-KO, N = 9).
(I) Ab40 monomers increase S in a dose-dependent manner in WT (N = 7–12), but not in APP/ (N = 6 – 12, p > 0.3), neurons. Error bars represent SEM.indicate that either endogenous or exogenous nontagged APP
molecules interact with the tagged APP, resulting in FRET reduc-
tion as predicted. Quantification of APPCit expression in axons of
APP/ neurons demonstrated amounts lower than or compara-
ble to endogenous presynaptic APP expression in WT neurons
(Figure S3), suggesting that FRET can occur under physiologi-
cally relevant APP levels. To rule out nonspecific association
due to overexpression of the tagged proteins, we cotransfected
APPCer and a nonrelated protein subunit of GABABRs, GB1a,
C-terminally taggedwith Cit (GB1a
Cit). These two tagged proteins
showed negligible FRET (Figure 2E). Furthermore, background
enhancement of Cer emission, assessed by photobleaching at
515 nm in neurons expressing only APPCer, was <2% (Figure 2E).1562 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The AuthorsTherefore, the higher FRET efficiencies measured between
APPCer and APPCit (p < 0.0001) are due to the specific asso-
ciations of APPCer and APPCit proteins. Altogether, these data
indicate that individual APP molecules occur in close proximity
in excitatory hippocampal boutons.
APP-APP Interactions Correlate to Release Probability
at Excitatory Synapses
Because release probability is highly heterogeneous across
hippocampal synapses (Laviv et al., 2010), we asked whether
APP-APP interactions vary across individual synapses and
correlate to synapse release probability. To directly address






Figure 2. APP Molecules form Homodimers in Activity-Dependent Manner at Single Hippocampal Boutons
(A) Schematic illustration of the fusion protein construct between APP and fluorophore (FP) used for FRET detection.
(B) Representative confocal images of hippocampal boutons of pyramidal neuron shown in Figure S4A that was cotransfected with APPCit and APPCer.
Arrowheads show the bouton that was bleached for calculation of FRET efficiency in (C). Scale bar, 2 mm.
(C) Pseudo-color-coded fluorescent images of APPCit and APPCer proteins expressed in a hippocampal bouton before and after Cit photobleaching. Note the
increase of Cer fluorescence (ex: 440 nm; em: 470–500 nm) after Cit (ex: 515 nm; em: 530–560 nm) photobleaching. Scale bar, 1 mM.
(D) Detection of mean FRET efficiency (Em) by spectral approach under 440 nm excitation in a single bouton. The donor emission peak is shown before and after
photobleaching.
(E) Summary of Em data for APP
Cer only (n = 13), APPCer /GB1aCit (n = 21), APPCer/APPCit expressed in WT neurons (n = 86), APPCer/APPCit expressed in APP/
neurons (n = 38) and APPCer/APPCit expressed in APP/ neurons with nontagged APP (APP-NT: n = 22). Error bars represent SEM.
(F) Measurement of release probability using FM4-64 and Em between APP
Cer and APPCit at the single-bouton level (F1). Scale bar, 1 mM. (F2) Pooled data across
12 boutons reveal a positive correlation between Em and the FM4-64 decay rate constant (Spearman r = 0.8, p < 0.01) but no correlation between the APP-
DGFLDCer-APP-DGFLDCit homodimer and the FM4-64 decay rate constant (Spearman r = 0.2, p > 0.6).
(G) Reduction in neuronal and synaptic activity decreased APPCer-APPCit FRET efficiency: tetrodotoxin (TTX, 0.5 mM; n = 51–75, p < 0.0001); u-conotoxin (CgTx)
and u-agatoxin (AgaTx) in the presence of TTX (n = 51–59, p < 0.001). Em was decreased in immature neurons (4–5 DIV, young: n = 30, N = 6, p < 0.01) and by
tetanus toxin (TeTx: n = 35, p < 0.05) and was significantly higher (p < 0.01) than nonspecific APPCer-GB1aCit FRET. Error bars represent SEM.
(H) Increase in neuronal and synaptic activity induces an augmentation in APPCer-APPCit Em: gabazine (GBZ: n = 40, N = 5, p < 0.002), an increase in [Ca
2+]o to
4.8 mM (High Ca2+: n = 38, p < 0.002); high-frequency 100 Hz stimulation (n = 14, p < 0.001). The extracellular solution included AP-5 (50 mM) and DNQX (10 mM).
Error bars represent SEM.indicator of release probability, together with FRET efficiency
measurements between APPCer and APPCit proteins at individual
boutons of pyramidal hippocampal neurons. The total pool of
recycling vesicles was stained by 600 action potentials at a
rate of 10 Hz, and the colocalized FM4-64/Cer/Cit puncta were
subjected to FRET analysis. The FM4-64 destaining rate (FiguresCS1C and S1D) and FRET efficiency between APPCer and APPCit
subunits were measured during 1 Hz stimulation. The FM de-
staining rate constant (k = 1/tdecay, where tdecay is an exponential
time course) is proportional to the probability of vesicle release
and was plotted against Em between APP
Cer and APPCit for
each imaged bouton (Figure 2F). The pooled data from 12ell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authors 1563
boutons demonstrate a positive correlation between Em and the
rate of FM destaining (Spearman r = 0.8, p < 0.01; Figure 2F2).
These results suggest that APP-APP interactions correlate to
release probability in excitatory hippocampal boutons.
Regulation of APP-APP Interactions by Neuronal and
Synaptic Activity
We next asked whether APP-APP interactions could be regu-
lated by the level of neuronal and synaptic activity. Activity levels
were altered using pharmacological agents or electrical stimula-
tion. FRET efficiency under spontaneous neuronal activity was
0.24 ± 0.015 (no blockers, Figure 2G). Spike blockade by
0.5 mM TTX triggered a 33% decrease in Em (p < 0.001; Fig-
ure 2G). To assess the changes in interactions between APPCer
and APPCit in the same synapse before and after pharmacolog-
ical treatment, we utilized the sensitized emission method by
monitoring the ratio of Cit to Cer emission under Cer excitation
(FRET ratio, defined as FR). FRwas also lowered after TTX appli-
cation (p < 0.0001; Figure S4A). Notably, TTX had no effect on Em
in APP molecules containing the endoplasmic reticulum (ER)
retaining motif KKQN (Shaked et al., 2006) (APP-KK, p = 0.75;
Figure S4B). Noteworthy, FRET between APP-KK was reduced,
but not abolished, indicating that the pool of APP in the ER exists
also as a complex. These results indicate that neuronal activity
may alter the number and/or conformation of APP-APP com-
plexes at the plasma membrane.
To test whether APP-APP interactions are regulated by neuro-
transmitter release, we measured the effects of presynaptic
calcium channels or soluble NSF attachment protein receptor
(SNARE)-dependent exocytosis blockers on APP conformation.
Blocking presynaptic Ca2+ flux through N- and P/Q-type calcium
channels byu-conotoxin andu-agatoxin resulted in reduction of
Em by 62% (p < 0.01; Figure 2G). Notably, measuring FRET
between APPCer and APPCit in immature (3–4 days in vitro
[DIV]) neurons, which lack the ability to recycle vesicles, revealed
a 75% reduction in Em (p < 0.01; Figure 2G) compared with
mature (12–14 DIV) cultured neurons. Finally, blocking SNARE-
dependent vesicle exocytosis by tetanus toxin (TeTx) reduced
FRET by 65% (p < 0.05; Figure 2G) but did not completely
abolish FRET between APPCer and APPCit as revealed by a com-
parison to the negative control (between APPCer andGB1aCit, p <
0.01; Figure 2G). These results indicate that synaptic activity is
not necessary for the basal APP-APP precoupling but is required
for the modulation of interactions between APP molecules.
Next, we explored whether these APP-APP interactions can
be tuned by spiking and synaptic release properties in the oppo-
site direction as well. Boosting neuronal activity by applying the
GABA(A) receptor blocker gabazine (GBZ, 30 mM) or by elevating
the extracellular Ca2+ levels from 1.2 to 4.8 mM (high Ca2+)
caused a 42% increase in FRET in both cases (p < 0.002; Figures
2H and S4C). Moreover, high-frequency (100 Hz) stimulation of
neurons triggered an 86% increase in FRET (p < 0.0001; Fig-
ure 2H and S4D). Notably, high-frequency stimulation had no
effect on Em in the presence of TeTx (Figure S4E), indicating
that SNARE-dependent vesicle release is required for changes
in APP-APP interactions. Altogether, these results indicate that
APP-APP interactions are positively modulated by neuronal
and synaptic activity.1564 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The AuthorsAb as the Mediator of Activity-Dependent APP-APP
Interactions
Because extracellular Ab concentration is directly regulated by
neuronal and synaptic activity (Cirrito et al., 2005; Kamenetz
et al., 2003), we asked whether Ab employs feedback regulation
bymediating the APP-APP conformational changes. To this end,
we utilized APP-M596V, which contains a point mutation that
blocks b-secretase cleavage and therefore Ab production (Citron
et al., 1995). APP-M596VCer and APP-M596VCit were transfected
in APP-KO cultures to ensure the lack of Ab production and
release. APP-M596V resulted in 2-fold lower (p < 0.0001) basal
FRET (0.12 ± 0.014; Figure 3A, no blockers) compared to APP-
WT (Figure 2G, no blockers). Moreover, APP-M596V abolished
bidirectional APP-APP FRET changes by neuronal activity (p >
0.6; Figure 3A).
We then directly explored the ability of Ab to induce APP-APP
conformational changes. First, we examined whether Ab40 in-
ducesFRETchangesbetween the taggedAPPmolecules inahet-
erologous expression systemusing human embryonic kidney 293
cells. Ab40 induced a 28% increase in the APP-APP FRET ratio
(p < 0.0001; Figures S5A and S5B). We next assessed the direct
effects produced by changes in [Ab]o on FRET between APP
Cer
and APPCit expressed in presynaptic boutons of hippocampal
neurons. Application of 100 pM Ab40 monomers or AbS26C
dimers to WT neurons increased Em by 65% ± 12% and 58% ±
16%, respectively (Figure 3B). Ab40 monomers triggered a 90%
increase in FRET efficiency in TeTx-treated neurons (Figure 3C),
meaning that synaptic activity is not required for the effect of Ab
on APP-APP interactions. In addition, a 1.5-fold increase in [Ab]o
induced by thiorphan (Th: 0.5 mM, 10 min) (Abramov et al.,
2009), an inhibitor of the Ab-degrading enzyme neprilysin, pro-
duced a 69% ± 14% increase in Em (Figure 3B). Reducing [Ab]o
by chelating endogenously released Ab via antibodies against
Ab decreased Em to 57% ± 9% (HJ5.1 antibody, p < 0.01; Fig-
ure 3B) and 58% ± 9% (82E1 antibody that does not recognize
a full-length APP, p < 0.05; Figure 3B), respectively. Moreover,
blocking Ab production by preincubation with g-secretase inhibi-
tor L-685,458 (GSI; 0.2 mM, 12 hr) reduced FRET by 51% ± 14%
(p < 0.01), while addition of Ab40 to neurons pretreated with GSI
increased FRET by 101% ± 15% compared to neurons treated
withg-secretase inhibitor (p < 0.01; Figure 3B). Notably, thiorphan
was not effective in neurons pretreated with g-secretase inhibitor
(Figure 3B), confirming specificity of its effect through Ab. Finally,
we measured FRET between APPCer and APPCit efficiency in
neuronal cultures produced from APP/PS1 transgenic mice (Jan-
kowskyet al., 2004), ananimalmodelof familial AD.APP/PS1neu-
rons overproduce Ab under varying patterns of neuronal activity
(Dolev et al., 2013), and indeed they displayed higher FRET
compared with WT neurons (p < 0.0001; Figure 3D). Moreover,
the application of thiorphan caused an additional 36% FRET in-
crease in APP/PS1 boutons (p < 0.0001; Figure 3D).
To verify these results and to determine the effect of Ab on
FRET efficiency within the fraction of interacting molecules (Ei),
we utilized 2pFLIM methodology (Bacskai et al., 2003; Yasuda
et al., 2006). In this method, a shortening in donor lifetime is
indicative of FRET. For this purpose, we used monomeric
enhanced green fluorescent protein (mEGFP) and mCherry as





Figure 3. Ab40 Is the Mediator of Activity-Dependent Changes in APP-APP Interactions
(A) In neurons expressing APP-M596VCer and APP-M596VCit in APP/ neurons, FRET was not affected by either TTX (n = 32, p > 0.6) or GBZ (n = 24–31, p > 0.5).
Error bars represent SEM.
(B) APPCer-APPCit Em increased with the application of 0.5 mM thiorphan (Th: n = 60–66, p < 0.001), 100 pM Ab40 monomers (n = 54–57, p < 0.001), and 100 pM
[Ab40S26C]2 (n = 43–54, p < 0.005) and decreased with the application of HJ5.1 antibody against Ab (10 mg/ml, n = 36–47, p < 0.01) and 82E1 antibody against Ab
(5 mg/ml, n = 19–23, p < 0.05). g-secretase inhibitor (GSI) reduced APPCer-APPCit Em (L-685,458, 0.2 mM: n = 27, p < 0.01). Application of thiorphan had no effect on
Em in the presence of GSI (n = 18, p < 0.01), while the addition of 100 pMAb40 in cultures treated by g-secretase inhibitor increasedAPP
CFP-APPYFPEm (n = 33, p <
0.01). Error bars represent SEM.
(C) Ab40 increased Em in TeTx-pretreated cultures (n = 26–32, p < 0.01). Error bars represent SEM.
(D) Em was higher in hippocampal cultures from APP/PS1 mice (n = 39–45, p < 0.001). The application of thiorphan to APP/PS1 neurons produced a further
increase in APPCer-APPCit FRET (n = 24, p < 0.001). Em measurements were performed in the presence of 0.5 mM TTX. Error bars represent SEM.
(E) APPGFP fluorescence lifetime images in hippocampal boutons transfected with APPmEGFP only (1) or cotransfected with APPmEGFP and APPmCherry (2). Scale
bar, 2 mm.
(F) Decay time constant of APPmEGFP in boutons expressing APPmEGFP (n = 68) and APPmEGFP and APPmCherry (n = 95).
(G) Em and Ei in boutons expressing APP
mEGFP and APPmCherry.
(H) The tAD was reduced by 100 pM Ab40 (n = 90, p < 0.0001), but increased by 0.2 mM GSI (n = 116, p < 0.0001). Error bars represent SEM.
(I) Ab40 increased FRET efficiency within the interacting molecules (n = 90, p < 0.0001), whereas GSI reduced it (n = 116, p < 0.0001). Error bars represent SEM.
(J) The APPmEGFP-APPmCherry binding fraction was not affected by Ab40 (n = 90, p > 0.4) or GSI (n = 116, p > 0.19). Error bars represent SEM.to APP (APPmEGFP) has a monoexponential lifetime decay, dis-
playing a time constant tD of 2.3 ± 0.007 ns (Figures 3E and
3F). We set out to measure FRET between APPmEGFP and coex-
pressed APPmCherry. The time constant of APPmEGFP was then
2.0 ± 0.01 ns (Figure 3F). In addition, fitting the fluorescence life-
time decays of the donor revealed that two donor subpopula-
tions exist under miniature synaptic activity. One subpopulation
(51.2% ± 1.4%) contains APPmEGFP proteins that interact with
APPmCherry, resulting in a shorter fluorescent lifetime tAD ofC1.7 ± 0.03 ns (Figures 3E and 3F). The remaining fraction consists
of free APPmEGFP proteins that display the characteristic slow
monoexponential lifetime of APPmEGFP monomers. FRET effi-
ciency within the interacting molecules (Ei) was 0.26 ± 0.01 (Fig-
ure 2H) and the mean FRET efficiency (Em) was 0.13 ± 0.07
(Figure 3G), supporting intensity-based FRET measurements.
Application of Ab40 monomers (100 pM, 15 min) resulted in an
increase of Ei from 0.25 ± 0.01 to 0.32 ± 0.01 (p < 0.0001; Fig-









B1 C1 Figure 4. Ab40 Increases the Fraction of APP
Homodimers at the Plasma Membrane of
Xenopus Oocytes
(A–C) Experiments in Xenopus oocytes expressing
WT APPmEGFP. (A) Images from representative
movies showing the expression of WT APPmEGFP in
Xenopus oocytes before (Cnt; A1) and 30 min after
(A2) the application of Ab40 (500 nM). (B) Fluores-
cence intensity trace of representative spots
bleaching in one and two steps indicated by arrows
before (B1) and after (B2) Ab40 application. (C)
Bleaching step analysis of 1,353 spots before (C1)
and 1,425 spots after (C2) the application of Ab40.
The error bars represent the counting uncertainty,
and the dashed red line indicates theoretical bino-
minal distribution for monomer with probability that
mEGFP is fluorescent = 0.80. In (C), error bars
represent SEM.
(D–F) Experiments in Xenopus oocytes expressing
APP-DGYENPTYmEGFP. (D) Images from represen-
tative movies showing expression of APP-
DGYENPTYmEGFP in Xenopus oocytes before (Cnt;
D1) and 30 min after (D2) the application of Ab40
(500 nM). (E) The fluorescence intensity trace of
representative spots bleaching in one and two
steps is indicated by arrows before (E1) and after
(E2) Ab40 application. (F) Bleaching step analysis
of 1,033 spots before (F1) and 1,040 spots after
(F2) the application of Ab40. The error bars repre-
sent the counting uncertainty. In (F), error bars
represent SEM.
(G) Ab40 increases the dimer fraction of WT APP
(n = 23, p < 0.01). Error bars represent SEM.
(H) APP dimer fraction is higher in oocytes
expressing APP-DGYENPTY versus WT APP (n =
13, p < 0.01). Error bars represent SEM.
(I) Ab40 increases APP-DGYENPT dimer fraction
(n = 14, p < 0.01). Error bars represent SEM.component of the biexponential fluorescence decay of
APPmEGFP coexpressed with APPmCherry (from 1.82 ± 0.02 to
1.55 ± 0.03 ns, p < 0.0001; Figure 3H). Conversely, blocking
Ab production by GSI increased tAD to 2.05 ± 0.03 (p < 0.0001;
Figure 3H), resulting in a decrease in the Ei to 0.17 ± 0.01 (p <
0.0001; Figure 3I). Neither Ab40 nor GSI affected the relative
fraction of APPmEGFP proteins that interact with APPmCherry (p >
0.4; Figure 3J), indicating that the total number of APP-APP
complexes per synapse does not seem to be affected by Ab.
Altogether, these results suggest that Ab40 is the extracellular
mediator translating alterations in neuronal activity to APP-APP
conformational changes.
Ab40 Increases the Fraction of APP Homodimers at the
Cytoplasmic Membrane
Next, we determined the stoichiometry of APP-APP interactions
and its regulation by Ab40 at the cytoplasmic membrane.
Because spatial resolution of existing imaging methods is insuf-
ficient to address this question at small central synapses, we
performed single-molecule subunit counting experiments
(Ulbrich and Isacoff, 2007) on homomeric APP in the plasma
membrane of Xenopus oocytes. Upon fusion of mEGFP to the
C terminus of APP (APPmEGFP) and low-density expression in1566 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authorsoocytes, we observed sparse, well-resolved and stationary
spots of green fluorescence on the plasmamembrane using total
internal reflection fluorescence (TIRF) microscopy (Figure 4A1).
The photobleaching of a single mEGFP is a discrete process;
thus, the fluorescence intensity of a protein complex with one
or several mEGFP molecules drops in a stepwise fashion, and
the number of steps reflects the number of mEGFP-tagged sub-
units in the complex. Fluorescence intensity trajectories (e.g.,
Figure 4B1) show that the majority of the APP
mEGFP spots
bleached in one step, with smaller numbers in two steps (Fig-
ure 4C1). Counting the bleaching steps from a total of 1,353
spots in 21 movies from nine different cells injected with
APPmEGFP resulted in 11.4% ± 1.1% of the APPmEGFP spots
that bleached in two steps (Figure 4C1). Notably, addition of
Ab40 induced a 1.7-fold increase in the fraction of APPmEGFP
spots bleached in two steps to 19.9% ± 1.5% (Figures 4A2–
4C2 and 4G), without affecting the number of APP
mEGFP
molecules on the cell surface (Figures S5E and S5F). These
results suggest that Ab40 increases the fraction of APP homo-
dimer complexes at the plasma membrane.
Ab40-induced increase in the steady-state APP homodimer
fraction at the cell surface may reflect dimerization of APPmEGFP
molecules in the plasma membrane or redistribution of
APPmEGFP dimers between the intracellular compartments and
the plasmamembrane. Given the immobility of bright fluorescent
APPmEGFP spots, we explored the second possibility by deletion
of the APP-GYENPTY internalization motif that inhibits clathrin-
dependent APP endocytosis (Perez et al., 1999). Notably, APP-
GYENPTY deletion resulted in 1.6-fold increase in the fraction
of APP-DGYENPTYmEGFP spots bleached in two steps to
17.7% ± 1.1% (Figures 4D1–4F1 and 4H). However, Ab40
induced an additional 1.6-fold increase in the fraction of APP-
DGYENPTYmEGFP spots bleached in two steps (28.6% ± 2%;
Figures 4D2–4F2 and 4I), similarly to its effect in WT APP
mEGFP
molecules. Thus, Ab40 increases the fraction of APP
homodimers at the plasma membrane irrespective of APP
internalization.
The E1 APP Domain Binds Ab40 Monomers and Dimers
Previous studies suggested two potential APP regions that
could directly interact with Ab: (1) the Ab homologous
sequence on APP (Shaked et al., 2006) and (2) the N-terminal
APP18-119 domain (Melchor and Van Nostrand, 2000; Van
Nostrand et al., 2002). Because deletion of the N-terminal
growth-factor-like domain (GFLD) from APP abolished the
correlation between APP-APP conformation and release prob-
ability (Figure 2F), we explored direct interactions between
Ab40 monomers or Ab40S26C dimers and the purified E1
domain of APP (Leu28-Ala198) that includes GFLD. We ex-
pressed and purified the E1 segment, as described previously
(Dahms et al., 2010). Purified E1 protein was primarily
monomeric, as determined by size-exclusion chromatography
multiangle light scattering (Figure S6A), and exhibited a pre-
dominantly helical secondary structure (Figure S6B), consistent
with the published crystal structure and indicative of proper
folding. To test whether E1 directly interacts with the smallest
Ab40 species, we performed a crosslinking assay with the
purified protein and Ab40 peptide. To minimize nonspecific
crosslinking, a mild crosslinker (disuccinimidyl suberate [DSS])
was used at a low concentration (50 mM). Following reaction
of E1 protein with different concentrations of monomeric
Ab40 in the presence of DSS, crosslinked products were
resolved by SDS-PAGE and detected by the 6E10 antibody
against the Ab40 N terminus (Figure 5A). Complex formation
was detected between E1 (21 kDa) and monomeric Ab40,
revealing a 25 kDa band (lane 1). Notably, higher concentra-
tions of monomeric Ab40 yielded an additional 29 kDa band,
corresponding to the complex of E1 with two molecules of
Ab40 (lanes 2 and 3), suggesting that the binding to E1 may
induce Ab40 dimerization. Increasing the E1 concentration
revealed increased crosslinking between E1 and either mono-
meric or dimeric Ab40 (lane 4). No complex formation was
detected in the absence of E1 (lane 5), Ab40 (lane 6), or DSS
(lane 7). Moreover, Ab40 did not dimerize in the absence of
E1. Underscoring the specificity of this interaction, no cross-
linking was detected between Ab40 and nonrelated purified
protein Tim44 (lane 11). Crosslinking of E1 and Ab40S26C di-
mers (Figure S2) yielded a dominant 29 kDa band (Figure 5A,
lane 8), consistent with E1:[AbS26C]2 complex. Notably, the
29 kDa band did not appear in the absence of E1 (lane 9) or
DSS (lane 10). Together, these results support direct and spe-Ccific E1:Ab40 interaction and may hint that the binding to E1
induces some degree of Ab40 oligomerization.
Next, we asked whether Ab40 binds to endogenous APP
expressed in neurons. For this purpose, hippocampal cultures
were incubated with biotinylated monomeric Ab40 (Ab40-biotin)
and then fixed and visualized with alkaline phosphatase conju-
gated to streptavidin using nitro-blue tetrazolium chloride/
5-bromo-4-chloro-3’-indolyl phosphate p-toluidine salt dye for
substrate as shown in Figure 5B. Saturable, concentration-
dependent Ab40-biotin binding to WT hippocampal neurons
was detected (Figure 5C). Given the wide variety of proposed
Ab binding candidates, we quantitated the contribution of
APP to the Ab40-biotin signal detected in WT neurons. Notably,
the fraction of the bound Ab40-biotin was reduced by 48%
in APP/ neurons in comparison to those in WT neurons (p <
0.0001; Figure 5D). Moreover, preincubation of WT cultures
with the 22C11 antibody raised against APP residues 66–81,
the potential Ab binding epitope, reduced the bound Ab40-biotin
fraction by 46% (p < 0.001; Figure 5D), consistent with the 22c11
antibody preventing Ab40-biotin binding to APP. Notably,
neither 22c11 antibody nor Ab40 affected the abundance of
APP molecules at the cell surface as estimated by TIRF micro-
scopy (p > 0.2; Figures S5E and S5F). Taken together, these
results suggest that neuronal APP represents a bona fide can-
didate for association with monomeric Ab40 and dimeric
Ab40S26C species.
APP-GFLD Is Critical for Ab-Induced Changes in APP-
APP Interactions
To explore whether the N-terminal APP domain is essential for
the Ab-induced changes in APP-APP interactions, we tested
the deletion of the N-terminal GFLD (Rossjohn et al., 1999) of
APP (D22–128; APP-DGFLD) on FRET between APP molecules
(Figure 6A). The basal FRET levels were not significantly different
between APP-DGFLD and APP-WT proteins (p > 0.1; Figure 6B).
However, in APP-DGFLD molecules, FRET lost its sensitivity to
all manipulations aimed at changing [Ab]o (p > 0.4; Figures 6C,
S5C, and S5D), suggesting that the APP-GFLD is required for
Ab-induced APP-APP conformational changes. It is noteworthy
that the GFLD deletion abolished the observed correlation
between FRET efficiency and FM dye release upon stimulation
(Spearman r = 0.2, p = 0.5; Figure 2F2). Moreover, addition of
the 22c11 antibody raised against the APP66-81 region within
the APP-GFLD increased the basal FRET (p < 0.01; Figure 6B)
and prevented further FRET modulation by TTX and Ab40 (p >
0.4; Figure 6D).
Next, we examined the importance of the Ab homologous
sequence on APP, which has been suggested to directly bind
Ab (Shaked et al., 2006), by replacing it with the cognate region
from APLP2, the sequence of which is divergent from APP (APP-
APLP2; Figure 6A). Both basal FRET (Figure 6B) and its regula-
tion by TTX and Ab40 (Figure 6E) were preserved in the chimeric
APP-APLP2 protein, thus ruling out the Ab homologous region in
APP as essential for Ab-dependent modulation of APP-APP in-
teractions. These experiments suggest that the GFLD of APP
constitutes the molecular determinant that regulates Ab-medi-
ated, activity-dependent modulation of conformational changes
within APP homodimers.ell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authors 1567
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Figure 5. Ab40 Monomers and Dimers Bind to APP
(A) A complex between E1 and Ab40 at different concentrations was formed by incubating the proteins for 10 min and subsequent addition of DSS (lanes 1–4).
Crosslinked products were analyzed by SDS-PAGE followed by western blotting with 6E10 antibody. Control experiments are shown in lanes 5–7. E1 and
[Ab40S26C]2 were incubated to allow complex formation under the same conditions as monomeric Ab40 (lane 8). The complex formed correlates with E1 and
[Ab40S26C]2. Control experiments for the dimeric crosslinking reaction are shown in lanes 9 and 10. Lane 11 is a negative control, replacing E1 with an unrelated
protein, Tim44 (44 kDa). SDS-PAGE was performed under reducing conditions.
(B) Representative images demonstrating binding of monomeric Ab40-biotin as visualized by alkaline phosphatase conjugated to streptavidin. Ab40-biotin
(500 nM) specifically binds to hippocampal neurons (14 DIV) in WT culture. The Ab40-biotin binding was reduced in APP/ neurons and by preincubation of WT
neurons with 22C11 antibody against the APP N terminus. Scale bar, 30 mM
(C) Dose dependence of Ab40-biotin binding to hippocampal neurons (n = 80–111). Error bars represent SEM.
(D) Preincubation of WT culture with 22C11 antibody against APP decreased Ab40-biotin binding to WT neurons by 46% (n = 110–167). Binding of Ab40-biotin to
APP/ neurons was reduced by 48% compared to binding in WT neurons (n = 324). Error bars represent SEM.APP-GFLD Is Required for the Ab-Mediated Presynaptic
Enhancement
Because Ab mediates enhancement of basal synaptic vesicle
release, we next examined whether it does so through the
APP-GFLD. First, we compared the effect of Ab on synaptic
vesicle recycling evoked by 0.2 Hz stimulation using FM1-43
dye in functional boutons of APP/ neurons versus boutons
expressing APP-WT or APP-DGFLD proteins. While Ab40 had
no effect on vesicle recycling in APP/ boutons (p > 0.7; Fig-
ures 1E–1I and 6G), its effect was rescued by expression of
the CFP-tagged APP-WT in APP/ neurons (p < 0.001; Figures
6F, 6G, and S7A). Moreover, Ab caused a 79% increase of the
presynaptic strength in the APP-APLP2 expressing boutons
(p < 0.0001; Figures 6G and S7A), suggesting that the Ab1568 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authorscognate APP’s domain is not essential for Ab-mediated pre-
synaptic enhancement. In contrast, Ab completely lost its ability
to increase synaptic vesicle turnover in neurons expressing
APP-DGFLD (p > 0.2; Figures 6F, 6G, and S7A) or APP-KK,
which is unable to reach the cell surface (p > 0.3; Figures 6G
and S7A), further supporting our hypothesis that APP serves
as a cell-surface receptor. Notably, the application of 22c11
antibody, which binds to the APP-GFLD and promotes APP-
APP interactions, increased synaptic vesicle recycling in WT
neurons (p < 0.0001; Figure 6H), mimicking the effect of Ab40.
Addition of Ab40 in 22c11-pretreated neurons did not produce
further enhancement of the presynaptic strength (p > 0.2; Fig-
ure 6H), while the boiled 22c11 did not interfere with the Ab40




Figure 6. APP-GFLD Is Required for Ab-Mediated APP-APP Conformational Changes and Presynaptic Enhancement
(A) Schematic illustration of the subdomains in the full and modified APP protein. All the constructs used for FRET detection were fused to Cit or Cer and the
C terminus.
(B) Emwas not significantly changed by deletion of GFLD (n = 62, p > 0.05) or replacing the Ab domain bymAPLP2 homolog (n = 28, p > 0.6) compared to APP-WT
Em levels (n = 106). Preincubation with 22C11 APP antibody elevated APP-WT Em (n = 68, p < 0.01). Emmeasurements were performed in the presence of 0.5 mM
TTX. Error bars represent SEM.
(C) APP-DGFLDCer-APP-DGFLDCit FRET (n = 85, p > 0.6) was not sensitive to TTX (n = 38, p > 0.6), 100 pMAb40 (n = 30, p > 0.8), 0.5 mM thiorphan (n = 16, p > 0.5),
HJ5.1 antibody against Ab (n = 16, p > 0.8), and TeTx (n = 40, p > 0.5). Error bars represent SEM.
(D) APPCer-APPCit FRET in culture preincubated with 22C11 APP antibody was not sensitive to TTX (n = 13–17, p > 0.8) and 100 pMAb40 (n = 60–72, p > 0.4). Error
bars represent SEM.
(E) TTX decreased APP-APLP2Cer-APP-APLP2Cit FRET by 33% (n = 28, p < 0.01), whereas 100 pM Ab40 increased FRET by 65% (n = 45, p < 0.01). Error bars
represent SEM.
(F) RepresentativeDFFM1-43 images before and 15min after application of 100 pMAb40 inAPP
/ neurons transfectedwith either APP-WTCFP or APP-DGFLDCFP.
Fluorescence intensities (arbitrary units) are coded using a pseudo-color transformation. Scale bar, 2 mM. Error bars represent SEM.
(G) Average magnitude of the effects produced by 100 pM Ab40 on S inAPP/ neurons transfected with different APPmutants (the same data as in B). Ab40 had
no effect on S in APP/ neurons transfected with Cer only (n = 20, p > 0.7), APP-KK (n = 13, p > 0.3), or APP-DGFLD (n = 33, p > 0.5). Ab40 increased S in APP/
neurons transfected with APP-WT (n = 38, p < 0.0001) and APP-APP-mAPLP2 (n = 12, p < 0.0001). Error bars represent SEM.
(H) Preincubation with 22c11 antibody (5 mg/ml, 2 hr) increased presynaptic strength in WT hippocampal neurons (n = 14, p < 0.0001). Ab40 (100 pM) was
ineffective (n = 14, p > 0.2) in 22c11-pretreated WT neurons. Error bars represent SEM.APP-GFLD is essential for the Ab-mediated presynaptic
enhancement.
APP/Go Protein Signaling Complex Mediates
Presynaptic Enhancement by Ab
We asked how APP-APP conformational changes are trans-
duced to augment synaptic release probability. Previous studies
proposed that the APP forms a complex with Go protein (Nishi-Cmoto et al., 1993; Swanson et al., 2005). Thus, we explored
whether Gi/o proteins mediate Ab-induced presynaptic enhance-
ment by testing the effect of pertussis toxin (PTX), which cata-
lyzes the ADP-ribosylation of a subunits of the heterotrimeric
Gi/o protein and uncouples it from the receptor, on the effect of
thiorphan or Ab40 on synaptic vesicle release. We found that
PTX profoundly reduced the effects of both thiorphan and
Ab40 on synaptic vesicle release (p < 0.0001; Figure 7A).ell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authors 1569
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Figure 7. Gi/o Protein Mediates Ab40-Induced Enhancement of Presynaptic Calcium Flux and Vesicle Release
(A) PTX pretreatment abolished enhancement of synaptic vesicle release caused by 0.5 mM thiorphan (N = 9, p < 0.001) or by 100 pM Ab40 (N = 9–12, p < 0.01).
Error bars represent SEM.
(B) FRET was detected between APPCit and Gao
CFP (n = 27), APPCit and Gb1
CFP (n = 25), and APPCit and Gg2
CFP (n = 66) proteins under miniature synaptic activity
at single hippocampal boutons. Lower Em was monitored between APP-D657-676
Cit and Gao
CFP (n = 24) and APP-D657-676Cit and Gg2
CFP (n = 15). To verify
FRET specificity, Em was measured between the CFP-tagged proteins of interest and nonrelated TNFR2
YFP. Error bars represent SEM.
(C) Deletion of APP-GFLD reduced APPCit-Gg2
CFP FRET by 57% (n = 43 - 46, p < 0.01) and APPCit-Gb1
CFP FRET by 54% (n = 24–31, p < 0.05). Error bars
represent SEM.
(D) Ab40 reduced APPCit-Gg2
CFP FRET by 58% (n = 74–82, p < 0.0001) and APPCit-Gb1
CFP FRET by 62% (n = 16–25, p < 0.05). 22c11 reduced APPCit-Gg2
CFP
FRET by 68% (n = 20–32, p < 0.0001) and APPCit-Gb1
CFP FRET by >90% (n = 44–56, p < 0.01). Error bars represent SEM.
(E) Spike-dependent presynaptic Ca2+ transients (DF/F) evoked by 0.2 Hz stimulation in WT, APP/, andMyrPhd-expressing WT neurons before and after Ab40
application. Ca2+ transients were quantified before (black) and after (red) Ab40 application (average of ten traces).
(F) Average data on Ab40-inducedmodification in Ca2+ transients normalized to control inWT (n = 48, p < 0.001),APP/ (n = 28, p > 0.8), andMyrPhd-expressing
(n = 21, p > 0.2) boutons. Error bars represent SEM.Next, we explored whether APP closely interacts with Go
proteins in presynaptic boutons by measuring possible FRET
between the tagged APP and Go protein subunits. FRET was
tested between APPCit and the CFP-tagged Gao subunit, where
CFP is internally inserted after E94 (Gao
CFP), Gg2 G protein
subunit N-terminally tagged to CFP (Gg2
CFP), and Gb1 G protein
subunit N-terminally tagged to CFP (Gb1
CFP) (Laviv et al., 2011).
Quantitative analysis of FRET signals across different boutons
revealed Em of 0.07 ± 0.01 for APP
Cit-Gao
CFP, 0.12 ± 0.02 for
APPCit-Gb1
CFP, and 0.09 ± 0.01 for APPCit-Gg2
CFP proteins
(Figure 7B). Notably, deletion of the APPHis657-Lys676 cyto-
plasmic domain, which has been proposed to mediate APP’s
interaction with Go protein (Nishimoto et al., 1993; Okamoto
et al., 1995), significantly reduced APP FRET with Gao
CFP and
Gg2
CFP (APP-D657–676; Figure 7B). The deletion of the APP-
GFLD reduced APP FRET with Gb1
CFP and Gg2
CFP (Figure 7C).
The application of Ab40 or 22c11 reduced APPCit-Gg2
CFP and
APPCit-Gb1
CFP FRET (Figure 7D), pointing to a modulation of1570 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The AuthorsAPP-Gb1g2 interactions by Ab in hippocampal boutons. Taken
together, these results suggest that APP forms a signaling
complex with Go proteins to mediate Ab-induced presynaptic
enhancement at presynaptic boutons.
Finally, we examined whether Ab potentiates vesicle release
by increasing presynaptic Ca2+ flux. Presynaptic Ca2+ transients
evoked by low-frequency stimulation were measured by high-
affinity fluorescent calcium indicator Oregon Green 488
BAPTA-1 AM. Ab40 had no effect on resting Ca2+-dependent
fluorescence, whereas it increased the size of action-potential-
dependent fluorescence transients (DF/F; Figure 7E). Ab40
induced a potentiation of presynaptic Ca2+ transients by
22% in WT neurons (p < 0.001; Figures 7E and 7F), whereas
it did not significantly affect Ca2+ transients in APP/ neurons
(p > 0.6; Figures 7E and 7F). Moreover, Ab40 effect on Ca2+
flux was prevented by transfection of WT neurons with the
membrane-targeted Gbg scavenger N-myristoylated phosducin





Figure 8. Ab40 Promotes APP-APP Inter-
actions at Mossy Fiber Terminals in Acute
Hippocampal Slices
(A) APPmEGFP and APPmCherry expression in the CA3
and dentate gyrus (DG) of APP/mice injected with
lentiviral vectors to the DG (A1). Zoom in to the DG
expression (A2). Scale bars represent 0.5 mm (A1)
and 0.1 mm (A2).
(B) In the CA3 area, mEGFP and mCherry fluo-
rescence is localized in the stratum lucidum where
the mossy fibers project. Mossy fiber terminals
positive for mEGFP and mCherry fluorescence and
color-coded APPmEGFP decay constant. Scale bar,
10 mm.
(C–E) Left: application of Ab40 (20 nM, 30 min, n =
58, seven slices from three mice) in hippocampal
slices of APP/ mice expressing APPmEGFP and
APPmCherry accelerated the decay constant of the
interacting molecules (C; tAD, p < 0.01) and
increased FRET efficiency between APPmEGFP and
APPmCherry coexpressed at mossy fibers (D; Ei, p <
0.01) but did not alter the fraction of interacting
APPmEGFP and APPmCherry (E; p = 0.3). Right: thio-
rphan treatment (20 mM, 30 min, n = 94, four slices
from two mice) accelerated tAD (C; p < 0.0001)
and increased Ei (D; p < 0.0001) but did not affect
the binding fraction (E; p = 0.48). Error bars repre-
sent SEM.indicating an involvement of Gbg subunits in this presynaptic
modulation.
Ab Regulates Presynaptic APP-APP Interactions in
Hippocampal Tissue
Finally, we extended the scope of our in vitro and cell-culture
study to acute hippocampal slices to gain information on the
regulation of presynaptic APP-APP interactions by extracellular
Ab levels in native brain tissue. We generated two lentiviral (LV)
vectors containing APPmEGFP and APPmCherry driven by the
CaMKII promoter for selective expression in excitatory neurons.
Concentrated viral particles of both LV vectors were injected in
the dentate gyrus (DG) of the hippocampal formation using a
stereotactic apparatus. After 1–2 months, the hippocampi of
the injected adultmicewere sliced and imaged. First, we injected
APPmEGFP and APPmCherry LVs in the DG of APP/ mice. Half
of the infected granule cells coexpressed APPmEGFP and
APPmCherry in the somatodendritic and axonic compartments of
the DG (Figures 8A and 8B). In the CA3 area (Figure 8B), fluo-
rescence was mainly observed in the stratum lucidum where
the mossy fibers project and make synapses with postsynaptic
cells. Tagged APP molecules appeared mainly as punctate
with a diameter of 2–5 mm that are reminiscent of the giant and
small mossy terminals (Acsa´dy et al., 1998). Using 2pFLIM, we
measured the lifetime of APPmEGFP at the mossy terminals coex-
pressing APPmCherry. The lifetime decay of the interacting pro-
teins was 1.94 ± 0.04 ns (Figure 8C), 19% lower than the one
measured at terminals expressing APPmEGFP alone (2.4 ±
0.02 ns). These data indicate an interaction between APPmEGFP
and APPmCherry molecules at mossy terminals, correspondingCto 0.24 ± 0.02 FRET efficiency (Figure 8D). Application of
monomeric Ab40 (20 nM, 30 min) led to a decrease in the lifetime
decay of APPmEGFP to 1.74 ± 0.07 ns in the terminals coexpress-
ing APPmCherry (p < 0.0001; Figure 8C), resulting in a 42%
increase in FRET efficiency to 0.34 ± 0.03 (p < 0.0001; Figure 8D).
Similar to the data in cultured neurons, the fraction of interacting
molecules per synapse was not changed by Ab40 application
(p = 0.3; Figure 8E).
Next, we injected APPmEGFP and APPmCherry LVs in the DG of
WT mice. To increase the extracellular levels of endogenous
Ab, we inhibited its neprilysin-mediated degradation by thio-
rphan. Application of thiorphan (20 mM, 30 min) lead to a
decrease in the lifetime decay of APPmEGFP from 1.89 ±
0.03 ns to 1.71 ± 0.04 ns in the terminals coexpressing
APPmCherry (p < 0.0001; Figure 8C), resulting in a 34% increase
in FRET efficiency to 0.39 ± 0.02 (p < 0.0001; Figure 8D) while
not affecting the fraction of interacting molecules per synapse
(p > 0.4; Figure 8E). These results indicate that extracellular Ab
promotes presynaptic APP-APP interactions in hippocampal
tissue.
DISCUSSION
Elucidating the mechanisms by which Ab peptides regulate
synaptic transmission is essential for understanding normal
synaptic function as well as early synaptic dysfunctions in AD.
In the current study, we found that APP binds Ab40 monomers
and dimers, increases the fraction of APP homodimers at the
plasma membrane, and induces activity-dependent APP-APP
conformational changes. APP homodimer activation, in turn,ell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authors 1571
leads to structural rearrangements within the presynaptic APP/
Go protein signaling complex, resulting in enhancement of
presynaptic calcium flux and, thus, synaptic vesicle exocytosis.
We identified the APP growth-factor-like domain as a critical
determinant of Ab40-induced changes in APP-APP interactions
and release probability. Collectively, our data delineate APP
homodimer as a presynaptic receptor that translates local
changes in the extracellular Ab levels to modulation of synaptic
release probability. This mechanism may maintain basal neuro-
transmitter release under physiological conditions and initiate
hippocampal hyperactivity under pathological conditions, pro-
moting a positive feedback loop leading to extracellular Ab
accumulation.
Activity Promotes APP-APP Interactions at
Hippocampal Boutons
Previous studies suggest that APP can form homodimers and
higher-order oligomers in heterologous expression systems
(Eggert et al., 2009; Kaden et al., 2009; Munter et al., 2007;
Scheuermann et al., 2001) and in brain homogenates (Bai
et al., 2008). Moreover, APP homodimerization seems to affect
Ab generation: dimerization strength in the transmembrane
GxxxG APP domain within the Ab sequence regulates the g-sec-
retase cleavage of APP, increasing the Ab42/40 ratio (Munter
et al., 2007). However, induced dimerization at the APP C termi-
nus reduced the total Ab production (Eggert et al., 2009). While
the structure and biological function of APP have been exten-
sively explored, several key questions remain unresolved to
date. First, do APP homodimers, localized at presynaptic
compartments, undergo modulation by endogenously released
Ab species? Second, does neuronal activity regulate APP-APP
interactions in neurons? Third, what is the effect of APP-APP in-
teractions on synaptic function?
Utilizing FRET spectroscopy and 2pFLIM-FRET, we were able
to monitor APP-APP interactions at individual presynaptic
boutons of live neurons in hippocampal cultures and acute
slices. The specific intermolecular FRET between APPCer and
APPCit was detected not only in WT neurons but also between
the tagged APP molecules expressed in APP/ neurons
(Figure 2E). While FRET methodology allows deciphering inter-
molecular interactions in small subcellular structures such as
synapses (Laviv et al., 2010), it requires expression of fluores-
cent-tagged proteins, raising the question of the possible effects
of protein overexpression. However, the following facts suggest
that homophilic APP interactions occur at physiologically rele-
vant APP levels. First, the level of the tagged APP expression
in the axons of APP/ neurons was similar to the endogenous
APP level in WT neurons (Figure S3). Second, the functional
effect of Ab40 in APP/ neurons expressing the tagged APP-
WT was comparable to those induced by Ab40 in WT neurons.
The observed intermolecular APP-APP FRET displayed consid-
erable variability among boutons (Figure 2F2). This heterogeneity
may derive from differences in the APP length (processed and
full), local mechanisms regulating APP-APP interactions or inter-
synapse differences in the microenvironment. Indeed, APP-APP
interactions display robust, rapid, and bidirectional regulation by
synaptic activity. Basal APP homodimerization did not require
synaptic activity, in agreement with an earlier study suggesting1572 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authorsthat APP dimers can form in the ER shortly after its synthesis
(Scheuermann et al., 2001). In contrast, APP-APP interactions
were modulated by spiking rate, Ca2+ flux through presynaptic
voltage-gated calcium channels, and synaptic release prob-
ability (Figure 2), while neuronal activity did not affect FRET
between APP-KK proteins containing an ER retention signal.
We conclude that the fraction of APP homodimers localized at
the cytoplasmic membrane is regulated by activity-dependent
conformational modifications.
Ab as the Mediator of Activity-Dependent APP-APP
Interactions
Spiking rate and synaptic activity could affect APP-APP confor-
mation either (1) by directly changing the membrane potential or
(2) through activity-dependent release of a putative mediator.
This second possibility, where extracellular Ab40 serves as the
mediator inducing APP-APP structural changes, is supported
by the following evidence: (1) Ab40 monomers and Ab40S26C
dimers directly bind to the E1 domain of the APP; (2) Ab40
increases the fraction of APP dimers at the plasma membrane
and FRET between APP molecules in heterologous expression
systems; (3) activity-dependent FRET changes were abolished
in neurons lacking Ab production following introduction of the
APP-M596V mutation preventing b-secretase cleavage; and (4)
FRET was altered by direct regulation of extracellular Ab levels.
Specifically, both antibody against Ab that does not recognize
full-length APP and g-secretase inhibitor reduced FRET. On
the other hand, inhibition of Ab degradation by thiorphan, the
addition of Ab40 monomers or Ab40S26C dimers, and an in-
crease in Ab production by APP/PS1 mutations boosted FRET
between APP molecules. Notably, the GFLD of APP constitutes
the molecular determinant required the activity-induced and
Ab-mediated APP-APP conformational changes.
What are the Ab species that induce an increase in glutamate
release? Our data provide evidence that Ab40 monomers and
dimers, the smallest Ab species, regulate presynaptic function
through activation of APP homodimers in hippocampal boutons.
This finding highlights a previously neglected role of Ab40mono-
mers in synaptic dysfunctions and is in contrast to an earlier
study in which cell media containing Ab monomers and SDS-
stable low-n oligomers had no effect on presynaptic function
estimated by paired-pulse ratio (Townsend et al., 2006). How-
ever, Ab dimers (from human brain as well as synthetic cross-
linked dimers) were suggested to represent the principal and
the smallest species that cause postsynaptic depression of
glutamatergic transmission via loss of dendritic spines, blockade
of long-term potentiation, and increase in long-term synaptic
depression (Shankar et al., 2008). Notably, later biophysical char-
acterization of Ab40S26C dimers point to the fact that it is not
dimers per se but rather protofibrils that mediate this activity
(O’Nuallain et al., 2010). Thus, it seems that the smallest Ab
species, monomers and dimers, enhance presynaptic function,
while higher-molecular-weight prefibrillar assembliesmay initiate
postsynaptic depression in excitatory synaptic connections.
APP Homodimer as a Presynaptic Ab40 Receptor
Does the APP homodimer, similar to the receptor tyrosine
kinases, trigger signal transduction through ligand-promoted
receptor dimerization? Although the APP structure is reminiscent
of other cell-surface receptors involved in signal transduction
(Kang et al., 1987), the role of APP as a bona fide surface re-
ceptor has remained speculative. Physical interaction between
pathological Ab levels/conformations and APP was proposed a
decade ago as a mechanism inducing neuronal death in AD
(Lorenzo et al., 2000; Shaked et al., 2006; Van Nostrand et al.,
2002). However, in addition to APP, a wide range of other
putative Ab receptors can induce neurotoxicity, suggesting
biophysical and structural heterogeneity of toxic Ab species or,
alternatively, nonspecific interactions between a mixture of toxic
peptides with cellular membranes and proteins (Benilova et al.,
2012).
Our data highlight the role of APP as a bone fide surface Ab40
receptor that triggers a signaling cascade leading to augmenta-
tion of synaptic vesicle release in hippocampal neurons. The full-
length APP may undergo cleavage by either a- or b-secretase,
resulting in the shedding of large extracellular portions of APP
termed APPsa or APPsb, respectively. Notably, b-secretase
mainly cleaves APP in the endosomal pathway (Koo and
Squazzo, 1994), while ADAM10 a-secretase resides in the
postsynaptic densities (Marcello et al., 2007). Thus, the pre-
synaptic plasma membrane appears to be the primary location
of unprocessed APP molecules that transduce changes in Ab
levels to synaptic strength.
How does Ab exert its presynaptic effect? Following secretion,
Ab forms the Ab:APP complex that triggers APP-APP conforma-
tional changes, leading to an increases in the presynaptic Ca2+
flux and subsequent potentiation of synaptic vesicle release.
Because Ab-mediated enhancement of Ca2+ flux or vesicle
release was prevented by either PTX or Gbg scavenger, we
concluded that Gi/o proteins are involved in this signaling
cascade. Moreover, we observed a close interaction between
APP molecules and Gaob1g2 protein subunits at individual
presynaptic boutons, suggesting a formation of the signaling
complex that is undergoing conformational changes by the
smallest Ab40 species. Reduction in APP/Go protein interactions
at various stages of cognitive decline in AD patients (Shaked
et al., 2009) indicates the importance of the APP/Go protein
signaling complex in AD progression.
Synapse Hyperactivity and Alzheimer’s Disease
Numerous human and animal studies suggest the role of
cortical and hippocampal hyperactivity in AD pathogenesis.
High default activity in specific brain regions of young adults
correlates with the spatial pattern of amyloid depositions in
elderly individuals with AD (Buckner et al., 2005). Aberrant
neuronal activity in the hippocampus and cortex has been re-
ported in humans with mild cognitive impairment (Bakker
et al., 2012), in AD patients (Vossel et al., 2013), and in familial
AD transgenic animal models (Busche et al., 2008; Palop et al.,
2007; Verret et al., 2012). Various molecular and cellular
mechanisms may contribute to brain hyperactivity in AD. For
example, deficits in parvalbumin-positive interneurons have
been proposed to underlie abnormalities in network synchrony
and cognitive functions in APP transgenic mice (Verret et al.,
2012). Young APP/PS1 transgenic mice exhibit increased basal
glutamate release in CA3-CA1 hippocampal connections (DolevCet al., 2013) and increased spontaneous Ca2+ transients in vivo
in pyramidal neurons in the CA1 region of hippocampus
(Busche et al., 2012). Notably, hyperactivity of pyramidal neu-
rons has been reported to occur before neuronal depression
and plaque deposition in the hippocampus of APP/PS1 mice
(Busche et al., 2012). Based on the current work, we propose
that increases in the extracellular level of Ab monomers and
dimers in the early stages of AD development may augment
signaling via APP homodimers, leading to hyperactivity of excit-
atory hippocampal synapses (Figure S8). Potentiation of synap-
tic vesicle release in turn causes a subsequent increase in Ab40
production and release (Cirrito et al., 2005; Dolev et al., 2013),
leading to a positive feedback loop between the extracellular
Ab concentration and basal glutamate release. Under physio-
logical conditions, an increase in Ab-mediated APP homodime-
rization may induce a feedback inhibition of Ab production
(Eggert et al., 2009) to maintain steady-state Ab levels and
basal glutamate release. Disruption of this negative feedback
loop by genetic- or experience-dependent factors may cause
a gradual increase in the extracellular levels of Ab monomers
and dimers during the early AD stages, leading to excessive
activation of APP homodimers at the plasma membrane and
subsequent hyperactivity of excitatory hippocampal synapses.
The described presynaptic hyperactivity may initiate neural
dysfunctions by two possible ways. First, it may cause deficits
in short-term synaptic plasticity (Abramov et al., 2009). Second,
it may facilitate the kinetics of Ab oligomerization and thus
depress synapses and induce synapse loss. Such an
Ab-induced synaptic reorganization may promote homeostasis
of synaptic output across the dendrites but reduce the ability of
synaptic networks to undergo experience-dependent modifica-
tions. It remains to be seen whether excessive activation of APP
homodimers by Ab emerges as the first molecular step contrib-
uting to hippocampal hyperactivity in the most frequent, spo-
radic AD.
EXPERIMENTAL PROCEDURES
Primary Hippocampal Cultures and Acute Hippocampal Slices
Primary cultures of CA3-CA1 hippocampal neurons were prepared from
newborn Sprague-Dawley rats and from APP/ (Zheng et al., 1995) and
corresponding WT mice (C57BL/6J background) on postnatal days 0–2, as
described previously (Abramov et al., 2009). Acute hippocampal slices were
prepared from 2- to 3-month-old APP/ and BALB/c mice 1month after lenti-
virus injections. All animals were kept in a normal light/dark cycle (12 hr/12 hr)
with three animals per cage. Coronal slices (400 mm) of hippocampus were
prepared as described before (Abramov et al., 2009). Slices were transferred
to a submerged recovery chamber at room temperature containing oxygen-
ated (95% O2 and 5% CO2) artificial cerebrospinal fluid (ACSF) for 1 hr before
the experiment. The ACSF contained, in mM, NaCl, 125; KCl, 2.5; CaCl2, 1.2;
MgCl2, 1.2; NaHCO3, 25; NaH2PO4, 1.25; glucose, 25. All animal experiments
were approved by the Tel Aviv University committee on animal care.
Confocal Imaging
Hippocampal neurons were imaged using a FV1000 spectral Olympus
confocal microscope using a 60 3 1.2 numerical aperture (NA) water-immer-
sion objective. The experiments were conducted at room temperature in extra-
cellular Tyrode solution containing (in mM) NaCl, 145; KCl, 3; glucose, 15;
HEPES, 10; MgCl2, 1.2; CaCl2, 1.2 (pH adjusted to 7.4 with NaOH). To isolate
miniature synaptic activity, TTX (0.5 mM) was added to the extracellular solu-
tion when indicated.ell Reports 7, 1560–1576, June 12, 2014 ª2014 The Authors 1573
FRET Imaging and Analysis
Intensity-based FRET imaging was carried as described before (Laviv et al.,
2010). Donor dequenching due to the desensitized acceptor was measured
from Cer emission (460–500 nm) before and after the acceptor photobleach-
ing. Mean FRET efficiency, Em, was then calculated using the equation Em =
1  IDA/ID, where IDA is the peak of donor emission in the presence of the
acceptor and ID is the peak after acceptor photobleaching (see Supplemental
Experimental Procedures for details).
2pFLIM Imaging and Analysis
For imaging in primary cultures, hippocampal neurons were transfected
with mEGFP-tagged APP (APPmEGFP) only or APPmEGFP together with APP
tagged with mCherry (APPmCherry) and visualized 24–36 hr later in Tyrode
solution. Fluorescence lifetime images were acquired with a two-photon
microscope (LSM 7 MP, Zeiss) coupled to the Becker and Hickl (BH) simple-
Tau-152 system. Chameleon Ti:Sapphire laser system with a 80 MHz repeti-
tion rate was used to excite the sample. Images were acquired through a
Zeiss 63 3 1 NA water-immersion objective for primary cultures and through
a Zeiss 203 1 NAwater-immersion objective for the acute brain slices. A Zeiss
dichroic mirror (T690) was used to separate the excitation and the emission
light. An additional barrier filter was used to block emission light above
690 nm. Images of 512 3 512 pixels were acquired at a scanning speed of
1.27 ms per pixel. Emission light was separated by a dichroic mirror
(555 nm), and the two fluorescent lights were filtered by two band-pass filters
(500–550 nm for mEGFP and 590–650 nm for mCherry) placed in front of two
hybrid GaAsP detectors (HPM-100-40, BH). The excitation wavelength was
920 nm for the donor fluorophore mEGFP and 1,020 nm for the acceptor
fluorophore mCherry. The image acquisition time was 100–120 s to collect a
sufficient number of photons. Images were analyzed using the SPCImage
software (BH). Regions of interest were marked at boutons. The instrument
response function was determined manually and was convoluted with the
exponential decay. The lifetime of the donor fluorophore (mEGFP) was then
fitted using a monoexponential decay model when APPmEGFP was expressed
alone and biexponential one when APPmEGFP was coexpressed with
APPmCherry. Monoexponential fit (F(t) = F0.exp
(t/tD)) determines the time
constant for APPmEGFP lifetime at boutons, tD. F0 is the initial photon counts.
Biexponential decay model is composed of a FRET (fast) and a non-FRET
(slow) components: F(t) = F0.[a1.exp
(t/tAD) + (100  a1)exp(t/tD). In the case
of a biexponential fit, tm was calculated as tm = a1.tAD + (100  a1).tD.
FM-Based Imaging and Analysis
Activity-dependent FM1-43 and FM4-64 styryl dyes have been used to esti-
mate basal synaptic vesicle recycling and exocytosis. Action potentials have
been elicited by passing 50mA constant current for 1 ms through two platinum
wires, separated by 7 mm and close to the surface of the coverslip. The
extracellular medium contained nonselective antagonist of ionotropic gluta-
mate receptors (kynurenic acid, 0.5 mM) to block recurrent neuronal activity.
Synaptic vesicles were loaded with 15 mM FM4-64 or 10 mM FM1-43. FM
loading and unloading were done using protocols described previously (Abra-
mov et al., 2009). The fluorescence of individual synapses was determined
from the difference between images obtained after staining and after destining
(DF). To estimate vesicle recycling/release during low-frequency stimulation,
we quantified (1) the DF signal for staining by 30 action potentials at a rate of
0.2 Hz stimulation (Figure S1A) and (2) the FM destaining rate during 1 Hz stim-
ulation following staining of boutons by maximal stimulation (Figure S1C).
Detection of signals has been done using custom-written scripts in MATLAB
(Mathworks) as described before (Abramov et al., 2009).
Statistical Analysis
Error bars shown in the figures represent SEM. The number of boutons is
defined by n and the number of experiments (cultures) by N. All the experi-
ments were repeated at least in three different batches of cultures. One-way
ANOVA analysis with post hoc Dunnett or Bonferroni correction was used to
compare several conditions. Student’s unpaired t test was used in the exper-
iments where two populations of synapses were compared. Student’s paired
t test was used when the same population of synapses was tested before and
after treatment. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.1574 Cell Reports 7, 1560–1576, June 12, 2014 ª2014 The AuthorsAdditional experimental procedures can be found in the Supplemental
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